HALOZYME THERAPEUTICS INC's ticker is HALO and the CUSIP is 40637H109. A total of 177 filers reported holding HALOZYME THERAPEUTICS INC in Q4 2016. The put-call ratio across all filers is 1.62 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2016 | $13,740,000 | +359.2% | 1,390,733 | +461.4% | 0.01% | +366.7% |
| Q3 2016 | $2,992,000 | +51.0% | 247,706 | +7.8% | 0.00% | +50.0% |
| Q2 2016 | $1,982,000 | -7.9% | 229,716 | +1.1% | 0.00% | 0.0% |
| Q1 2016 | $2,151,000 | -44.6% | 227,105 | +1.4% | 0.00% | -50.0% |
| Q4 2015 | $3,882,000 | +9.0% | 223,987 | -15.6% | 0.00% | 0.0% |
| Q3 2015 | $3,563,000 | -9.1% | 265,306 | +52.9% | 0.00% | 0.0% |
| Q2 2015 | $3,919,000 | +194.4% | 173,567 | +86.3% | 0.00% | +300.0% |
| Q1 2015 | $1,331,000 | +141.6% | 93,186 | +63.3% | 0.00% | 0.0% |
| Q4 2014 | $551,000 | -40.2% | 57,061 | -43.7% | 0.00% | 0.0% |
| Q3 2014 | $922,000 | +32.1% | 101,351 | +43.5% | 0.00% | 0.0% |
| Q2 2014 | $698,000 | -46.5% | 70,612 | -31.3% | 0.00% | 0.0% |
| Q1 2014 | $1,305,000 | +47.1% | 102,727 | +73.6% | 0.00% | 0.0% |
| Q4 2013 | $887,000 | +46.1% | 59,162 | +7.6% | 0.00% | 0.0% |
| Q3 2013 | $607,000 | -59.0% | 54,979 | -70.5% | 0.00% | 0.0% |
| Q2 2013 | $1,482,000 | – | 186,506 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Third Security, LLC | 19,829,337 | $266,308,000 | 10.60% |
| BB BIOTECH AG | 6,929,832 | $93,068,000 | 2.95% |
| SECTORAL ASSET MANAGEMENT INC | 2,671,051 | $35,872,000 | 1.64% |
| Sterling Global Strategies LLC | 22,000 | $295,000 | 1.63% |
| Lombard Odier Asset Management (USA) Corp | 1,061,547 | $14,257,000 | 1.24% |
| PYRRHO CAPITAL MANAGEMENT, LP | 90,000 | $1,209,000 | 1.04% |
| IRIDIAN ASSET MANAGEMENT LLC/CT | 8,184,003 | $109,911,000 | 0.93% |
| Bellevue Asset Management AG | 246,000 | $3,304,000 | 0.54% |
| Convergence Investment Partners, LLC | 251,748 | $3,381,000 | 0.39% |
| Rhenman & Partners Asset Management AB | 172,000 | $2,310,000 | 0.37% |